SAB Biotherapeutics, Inc.
corporate_fare Company Profile
SAB Biotherapeutics, Inc. (NASDAQ:SABS) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for SABS at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- SAB Biotherapeutics Discloses Strong Cash Position and Extended Runway for T1D Program
- SAB Biotherapeutics Strengthens Board with New Chair David Zaccardelli and Director Rita Jain
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$0
Net Income
$13.27M
Diluted EPS
-$0.79
Op. Cash Flow
-$44.78M
Free Cash Flow
-$45.71M
Operating Income
-$48.95M
Cash & Equivalents
$10.5M
Debt / Equity
0.00×
Shares Outstanding
47.61M sh
Source: 10-K · filed 2026-03-09 · accession 0001833214-26-000003
show_chartPrice Chart
Loading chart...